Hisamitsu Pharmaceutical Co., Inc.
General ticker "HTSUY" information:
- Sector: Health Care
- Industry: Medical - Pharmaceuticals
- Capitalization: $2.0B (TTM average)
Hisamitsu Pharmaceutical Co., Inc. does not follow the US Stock Market performance with the rate: -37.0%.
Estimated limits based on current volatility of 0.0%: low 2.94$, high 2.94$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-08-29, amount 0.10$ (Y3.40%)
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-02-28 to 2028-02-28
- 2026-02-28 to 2027-02-28 estimated range: [5.86$, 8.69$]
- 2027-02-28 to 2028-02-28 estimated range: [6.38$, 9.34$]
Short-term HTSUY quotes
Long-term HTSUY plot with estimates
Financial data
| YTD | 2024-02-28 | 2025-02-28 | 2026-02-28 |
|---|---|---|---|
| Operating Revenue | $989.35MM | $1,022.99MM | $1,087.70MM |
| Operating Expenses | $897.41MM | $899.09MM | $968.15MM |
| Operating Income | $91.94MM | $123.91MM | $119.55MM |
| Non-Operating Income | $42.02MM | $64.20MM | $38.28MM |
| Interest Expense | $0.13MM | $0.15MM | $0.14MM |
| R&D Expense | $60.14MM | $71.50MM | $0.00MM |
| Income(Loss) | $133.95MM | $188.11MM | $157.83MM |
| Taxes | $33.19MM | $41.87MM | $27.38MM |
| Net Income(Loss)* | $97.53MM | $142.68MM | $127.84MM |
| Stockholders Equity | $1,769.74MM | $1,837.00MM | $1,869.14MM |
| Inventory | $141.48MM | $148.58MM | $166.00MM |
| Assets | $2,196.67MM | $2,276.57MM | $2,351.72MM |
| Operating Cash Flow | $18,188.00MM | $123.04MM | $116.61MM |
| Capital expenditure | $13,036.00MM | $89.35MM | $53.34MM |
| Investing Cash Flow | $-2,512.00MM | $115.15MM | $-112.53MM |
| Financing Cash Flow | $-16,691.00MM | $-103.92MM | $-134.76MM |
| Earnings Per Share** | $0.32 | $0.48 | $0.45 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.